Skip to main content

Nutex Health Inc.

corporate_fare Company Profile

Nutex Health Inc.

NUTX·NASDAQ·Trade & Services·CIK 0001479681

Nutex Health Inc. is a physician-led healthcare services and operations company. As of December 31, 2025, the company operates 26 hospital facilities across 12 states through its hospital division and manages a primary care-focused, risk-bearing population health management division. The company employs 944 full-time employees, contracts over 280 doctors at its facilities, and partners with more than 3,600 physicians and specialists within its independent physician association (IPA) networks. Its corporate headquarters is in Houston, Texas. Nutex Health was incorporated on April 13, 2000, in Delaware. The company reports its operations across three segments: the hospital division, the population health management (PHM) division, and the real estate division. The hospital division develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs), offering 24/7 care. These facilities provide emergency room care, inpatient care, behavioral health, and ancillary services such as onsite imaging (CT scan, X-ray, MRI, ultrasound) and certified laboratories. As of December 31, 2025, this division owned and operated 26 healthcare facilities and had nine additional micro-hospitals under development. The hospital division typically operates as an out-of-network provider, with patients using out-of-network benefits and co-pays to settle invoices. The PHM division owns and operates provider networks, including IPAs.

Nutex Health Inc. (NASDAQ:NUTX) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 17 items for NUTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NUTX spans 8-K, 10-Q, DEF 14A, 10-K.

Recent high-impact activity:

  • Nutex Health Declares First-Ever $2.00/Share Special Cash Dividend
  • Nutex Q3 Revenue Tops Estimates at $217.6M; Net Income Figure Conflicts With Filing
  • Nutex Q3 Profit Falls to $40.2M as Hospital Revenue Drops 19.7%
  • Nutex Health Confirms Stolen Data Published by Attacker
  • Class Action Filed Against Nutex Health Over Data Breach

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$875.26M
Net Income
$70.79M
Diluted EPS
$10.48
Op. Cash Flow
$248.13M
Free Cash Flow
$245.6M
Gross Profit
$444.28M
Operating Income
$275.63M
Cash & Equivalents
$185.57M
Total Debt
$42.51M
Debt / Equity
0.13×
Net Margin
8.1%
Shares Outstanding
7.09M sh
Source: 10-K · filed 2026-03-05 · accession 0001628280-26-015168

Short Interest & Short Volume

10.09 days to cover

FINRA reported short interest of 1,164,595 shares in NUTX as of the October 30, 2026 settlement, a 5.9% decrease from the prior period — about 10.1 days to cover at its recent average daily volume. On November 20, 2026, 68.7% of NUTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,164,595 shares as of October 30, 2026
Change vs prior period▼ 5.9%
Days to cover10.09 at avg daily volume of 115,422
Daily short volume (FINRA facilities)68.7% of 59,066 shares on November 20, 2026
5-day average short volume63.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with N →
$173.01 +0.16% today
52-week range · as of 2026-11-17 $83.99 – $226.16
Market cap
$1.12B
Volume
157.5K (1.2× avg)
3-mo avg 135.1K
Live data · 2026-11-21 10:27 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NUTX - Latest Insights

NUTX
Nov 17, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $169.87
Real-time Price: $173.01 info
Change: +$3.14 (+2%) info
Market Cap: $1.116B info
NUTX
Nov 05, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $193.64
Real-time Price: $173.01 info
Change: -$20.63 (-11%) info
Market Cap: $1.116B info
NUTX
Nov 05, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $193.64
Real-time Price: $173.01 info
Change: -$20.63 (-11%) info
Market Cap: $1.116B info
NUTX
Sep 10, 2026, 5:53 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $195.20
Real-time Price: $173.01 info
Change: -$22.19 (-11%) info
Market Cap: $1.116B info
NUTX
Aug 31, 2026, 4:33 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $188.76
Real-time Price: $173.01 info
Change: -$15.75 (-8%) info
Market Cap: $1.116B info
NUTX
Aug 31, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $188.76
Real-time Price: $173.01 info
Change: -$15.75 (-8%) info
Market Cap: $1.116B info
NUTX
Aug 24, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $187.60
Real-time Price: $173.01 info
Change: -$14.59 (-8%) info
Market Cap: $1.116B info
NUTX
Aug 24, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $187.60
Real-time Price: $173.01 info
Change: -$14.59 (-8%) info
Market Cap: $1.116B info
NUTX
Aug 13, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $186.81
Real-time Price: $173.01 info
Change: -$13.80 (-7%) info
Market Cap: $1.116B info
NUTX
Aug 06, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.00
Real-time Price: $173.01 info
Change: +$8.01 (+5%) info
Market Cap: $1.116B info
NUTX
Apr 30, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $121.80
Real-time Price: $173.01 info
Change: +$51.21 (+42%) info
Market Cap: $1.116B info
NUTX
Apr 30, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $121.80
Real-time Price: $173.01 info
Change: +$51.21 (+42%) info
Market Cap: $1.116B info
NUTX
Apr 30, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $121.80
Real-time Price: $173.01 info
Change: +$51.21 (+42%) info
Market Cap: $1.116B info
NUTX
Mar 13, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $88.80
Real-time Price: $173.01 info
Change: +$84.21 (+95%) info
Market Cap: $1.116B info
NUTX
Mar 11, 2026, 5:05 PM EDT
Source: Acceswire
Importance Score:
8
Price at Filing: $90.49
Real-time Price: $173.01 info
Change: +$82.52 (+91%) info
Market Cap: $1.116B info
NUTX
Mar 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.34
Real-time Price: $173.01 info
Change: +$101.67 (+143%) info
Market Cap: $1.116B info
NUTX
Mar 05, 2026, 4:10 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $71.31
Real-time Price: $173.01 info
Change: +$101.70 (+143%) info
Market Cap: $1.116B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets